Association between air pollution and incident cardiovascular diseases among a population with cardiovascular-kidney-metabolic syndrome stages 0–3: the first evidence from the China Health and Retirement Longitudinal Study - Takeaways - MDSpire

Association between air pollution and incident cardiovascular diseases among a population with cardiovascular-kidney-metabolic syndrome stages 0–3: the first evidence from the China Health and Retirement Longitudinal Study

  • By

  • Hongbo Huang

  • Yunhai Li

  • Ze Zhang

  • Yijing Xu

  • Linfeng Xie

  • Ying Huang

  • Tingting Wei

  • Haonan Pan

  • Zhiqi Hu

  • Zhen Gong

  • Jiaying Li

  • Yichen Wang

  • Aijie Zhang

  • Fan Li

  • June 23, 2026

  • 0 min

Share

  • 1

    The study evaluated the relationship between air pollution exposure and cardiovascular disease (CVD) incidence in individuals with cardiovascular–kidney–metabolic syndrome.

  • 2

    Among 7400 individuals studied, 21.8% experienced CVD events, including 1212 heart disease cases and 551 strokes over a 7-year follow-up.

  • 3

    Increased exposure to PM1, PM2.5, PM10, and NO2 was associated with higher risks of new-onset CVD, while O3 showed no significant association.

  • 4

    Lower educational attainment was linked to greater risk of incident CVD and heart disease associated with air pollution exposure.

  • 5

    Metabolic syndrome partially mediated the relationship between air pollution exposure and CVD risk among the studied population.

Original Source(s)

Association between air pollution and incident cardiovascular diseases among a population with cardiovascular-kidney-metabolic syndrome stages 0–3: the first evidence from the China Health and Retirement Longitudinal Study

  • by Hongbo Huang, Yunhai Li, Ze Zhang, Yijing Xu, Linfeng Xie, Ying Huang, Tingting Wei, Haonan Pan, Zhiqi Hu, Zhen Gong, Jiaying Li, Yichen Wang, Aijie Zhang, Fan Li

  • June 23, 2026

Related Content

The Proteomics of Precision – with Jennifer Van Eyk

Ahead of ISC2026 in Prague, Jennifer Van Eyk explains how scalable LC-MS workflows and single-cell proteomics are helping reveal the biological differences that could make precision medicine a clinical reality

One-year outcomes of thoracic endovascular stent graft repair for acute type B aortic penetrating ulcer combined with antiplatelet drugs

External factors show reproducible local symptom-biomarker associations in middle-aged and older adults with heart disease